Validation and reliability of the Turkish version of the composite autonomic symptom score 31.

Autor: Is EE; Department of Physical Medicine and Rehabilitation, University of Health Sciences, Sisli Hamidiye Etfal Teaching and Research Hospital, Istanbul, Turkey. enefeis@gmail.com.; Department of Physical Medicine and Rehabilitation, Sisli Hamidiye Etfal Teaching and Research Hospital, Seyrantepe Campus, Cumhuriyet ve Demokrasi Avenue, Sariyer, Istanbul, Turkey. enefeis@gmail.com., Ciftci Inceoglu S; Department of Physical Medicine and Rehabilitation, University of Health Sciences, Sisli Hamidiye Etfal Teaching and Research Hospital, Istanbul, Turkey., Tekin SC; Department of Physical Medicine and Rehabilitation, University of Health Sciences, Sisli Hamidiye Etfal Teaching and Research Hospital, Istanbul, Turkey., Albayrak B; Department of Public Health, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey., Sonsoz MR; Department of Cardiology, Başakşehir Çam & Sakura City Hospital, Istanbul, Turkey., Kuran B; Department of Physical Medicine and Rehabilitation, University of Health Sciences, Sisli Hamidiye Etfal Teaching and Research Hospital, Istanbul, Turkey., Singer W; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Jazyk: angličtina
Zdroj: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2024 Dec; Vol. 45 (12), pp. 5779-5786. Date of Electronic Publication: 2024 Sep 24.
DOI: 10.1007/s10072-024-07776-2
Abstrakt: Objectives: This study aimed to validate a Turkish version of the Composite Autonomic Symptom Score 31 (T-COMPASS 31) for assessing autonomic dysfunction.
Patients and Methods: The COMPASS 31 questionnaire was translated into Turkish following a rigorous protocol. Forty-five patients with autonomic dysfunction symptoms related to their primary disease and 45 healthy controls matched for age and sex participated in the study. All participants completed the T-COMPASS 31 twice, with a six-week interval between administrations.
Results: The T-COMPASS 31 demonstrated strong test-retest reliability, with scores remaining consistent upon retesting. Internal consistency analysis yielded high scores, indicating the questionnaire's effectiveness in accurately measuring autonomic dysfunction. Patients with autonomic dysfunction had significantly higher T-COMPASS 31 scores compared to healthy controls, thus supporting the validity of the T-COMPASS 31 as a tool for detecting this condition.
Conclusion: This study successfully validated the T-COMPASS 31, establishing it as a reliable and accurate method for assessing autonomic dysfunction in Turkish-speaking populations.
Competing Interests: Declarations Ethics approval The local hospital ethics committee granted ethical approval for the study on November 1, 2022 (Approval No: 2177). Conflict of interest No conflict of interest was declared by the authors. Informed consent to participate the study and for publication All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Institutional Ethics Committee of the Sisli Hamidiye Etfal Teaching and Research Hospital had approved the study, and written informed consent had been obtained from all study participants. Disclosure All authors read and approved the final version of the manuscript.
(© 2024. Fondazione Società Italiana di Neurologia.)
Databáze: MEDLINE
Externí odkaz: